THE PROGNOSTIC SIGNIFICANCE OF MYC AND BCL2 PROTEIN DOUBLE EXPRESSION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, NOS, IN THE ABSENCE OF MYC REARRANGEMENT

被引：0
|
作者：
Fraenza, C. [1 ]
Bernasconi, R. [1 ]
Parisi, A. [1 ]
Tisi, M. C.
Riva, M. [2 ]
Moretta, F. [3 ]
Brighenti, A. [3 ]
Ferrarini, I. [1 ]
Tanasi, I. [1 ]
Quaglia, F. M. [1 ]
Krampera, M. [1 ]
Visco, C. [1 ]
机构：
[1] Univ Studi Verona, Verona, Italy
[2] Osped San Bortolo, Bortolo, Italy
[3] IRCSS Ospedale Sacro Cuore Don Calabria, Calabria, Italy
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P48
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [31] Myc and Bcl2 double expression does not impact on the prognosis of pediatric diffuse large B-cell lymphoma and high-grade B-cell lymphoma, NOS: a multicenter Italian study
    Pizzi, Marco
    Bellan, Alberto
    Pillon, Marta
    Carraro, Elisa
    Massano, Davide
    Mussolin, Lara
    Lovisa, Federica
    D'Amore, Emanuele
    Rugge, Massimo
    MODERN PATHOLOGY, 2019, 32
  • [32] MYC-Rearrangement and MYC/BCL2 Double Expression but not Cell-of-Origin Predict Prognosis in de novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Liu, Jing-Lan
    Medeiros, L. Jeffrey
    Huang, Wenting
    McDonnell, Timothy
    Miranda, Roberto
    Bueso-Ramos, Carlos
    Schlette, Ellen
    Lin, Pei
    Li, Shaoying
    MODERN PATHOLOGY, 2018, 31 : 534 - 534
  • [33] MYC-Rearrangement and MYC/BCL2 Double Expression but not Cell-of-Origin Predict Prognosis in de novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Liu, Jing-Lan
    Medeiros, L. Jeffrey
    Huang, Wenting
    McDonnell, Timothy
    Miranda, Roberto
    Bueso-Ramos, Carlos
    Schlette, Ellen
    Lin, Pei
    Li, Shaoying
    LABORATORY INVESTIGATION, 2018, 98 : 534 - 534
  • [34] Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
    Sermer, David
    Bobillo, Sabela
    Dogan, Ahmet
    Zhang, Yanming
    Seshan, Venkatraman
    Lavery, Jessica A.
    Batlevi, Connie
    Caron, Philip
    Hamilton, Audrey
    Hamlin, Paul
    Horwitz, Steven
    Joffe, Erel
    Kumar, Anita
    Matasar, Matthew
    Noy, Ariela
    Owens, Colette
    Moskowitz, Alison
    Palomba, M. Lia
    Straus, David
    von Keudell, Gottfried
    Rodriguez-Rivera, Ildefonso
    Falchi, Lorenzo
    Zelenetz, Andrew
    Yahalom, Joachim
    Younes, Anas
    BLOOD ADVANCES, 2020, 4 (14) : 3382 - 3390
  • [35] Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma
    Schneider, Kelli M. Clark
    Banks, Peter M.
    Collie, Angela M. B.
    Lanigan, Christopher P.
    Manilich, Elena
    Durkin, Lisa M.
    Hill, Brian T.
    Hsi, Eric D.
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1640 - 1648
  • [36] Clinicopathological differences in MYC and BCL2 protein expression between primary extranodal and nodal diffuse large B-cell lymphoma
    Sasaki, Yohei
    Murai, So
    Hayashi, Hidenori
    Kawamata, Natsuki
    Nagao, Kazuki
    Kuroiwa, Kai
    Narita, Hinako
    Okamura, Reiko
    Shimada, Shotaro
    Watanuki, Megumi
    Arai, Nana
    Kawaguchi, Yukiko
    Yanagisawa, Kouji
    Shiozawa, Eisuke
    Yamochi, Toshiko
    Hattori, Norimichi
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 260
  • [37] Impact of Cell of Origin, MYC/BCL2 Dual Expression and MYC Rearrangements in Diffuse Large B-Cell Lymphoma Patients Treated with Combined Modality Therapy
    Augustyn, A.
    Gunther, J. R.
    Medeiros, L. J.
    Milgrom, S. A.
    Nastoupil, L.
    Neelapu, S. S.
    Nair, R.
    Li, S.
    Ok, C. Y.
    Steiner, R. E.
    Iyer, S. P.
    Ahmed, S.
    Westin, J.
    Rodriguez, M. A.
    Pasalic, D.
    Fayad, L.
    Samaniego, F.
    Dabaja, B.
    Pinnix, C. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S248 - S248
  • [38] Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
    A Kawajiri
    D Maruyama
    A M Maeshima
    J Nomoto
    S Makita
    H Kitahara
    K-i Miyamoto
    S Fukuhara
    T Suzuki
    W Munakata
    K Tajima
    J Itami
    H Taniguchi
    Y Kobayashi
    K Tobinai
    Blood Cancer Journal, 2016, 6 : e477 - e477
  • [39] Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
    Kawajiri, A.
    Maruyama, D.
    Maeshima, A. M.
    Nomoto, J.
    Makita, S.
    Kitahara, H.
    Miyamoto, K-i
    Fukuhara, S.
    Suzuki, T.
    Munakata, W.
    Tajima, K.
    Itami, J.
    Taniguchi, H.
    Kobayashi, Y.
    Tobinai, K.
    BLOOD CANCER JOURNAL, 2016, 6 : e477 - e477
  • [40] Prognostic significance evaluation of B-cell lymphoma 2 (BCL2) and Ki-67 expression in diffuse large B-cell lymphoma patients
    Rahimi, Hossein
    Borojerdi, Zahra Rezaei
    Azimi, Sajad Ataei
    Rashidian, Elnaz
    Jafarian, Amirhossein
    IMMUNOPATHOLOGIA PERSA, 2020, 6 (01):
12345